SAN DIEGO, March 14, 2016 /PRNewswire/ -- Dexcom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System will support the Apple Watch enabling users to monitor their G5 Mobile glucose data using the app with one glance of their wrist. Users, as well as parents and caregivers, will be able to discreetly receive glucose readings and trends, alerts and notifications on Apple Watch, which syncs data directly from iPhone.
In addition, a new feature called Today view is now supported by the G5 app for iPhone, allowing users to easily and quickly check their CGM information without needing to open the app, even when the device is locked. The Today view widget is accessed by swiping down from the top edge of the screen, for greater ease of use and flexibility.
"The Dexcom G5 Mobile interface with Apple Watch and the new Today view widget allows us to continue to enhance options and product offerings that include even more useful features for people with diabetes," said Kevin Sayer, Chief Executive Officer of Dexcom. "These features were driven by feedback from G5 Mobile users, and showcase our commitment to continuously improve the user experience, making CGM more flexible than ever before for people with diabetes to manage their condition."
Available by prescription, the Dexcom G5 Mobile CGM System - the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age - provides a simplified mobile interface with color dials and directional arrows that allow for easy viewing, identification and assessment of glucose status. The G5 device integrates with the Health App on iPhone, allowing users to share glucose data with other apps and, with user permission, enabling data to flow seamlessly from the G5 app into EHR software. The device includes a built-in alarm, customizable alerts and is the first to offer wireless Bluetooth® technology right in the transmitter of the device so users no longer need to carry a receiver with them. It comes with the longest-wear sensor on the market and features customizable alerts and a built-in low glucose alarm (55 mg/dL alarm) to warn patients of pending highs and lows so they can avoid potentially dangerous situations.
The transmitter securely sends vital glucose information directly to the Dexcom G5 Mobile app on an iOS device for real-time diabetes management. Like its predecessor, the G4 PLATINUM CGM with Share, users can also select up to five designated recipients, or "followers." These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere. In addition, a patient's glucose data is wirelessly transferred via secure measures to a cloud-based diabetes software management system called Dexcom Clarity for easy sharing with health care professionals and personalized, easy to understand analysis of glucose patterns leading to improved diabetes management.
Continuous glucose monitoring is considered the most significant breakthrough in diabetes management in the past 40 years1. The traditional standard-of-care for glucose (blood sugar) monitoring has been a finger stick meter. CGM augments the use of glucose meters for the management of diabetes. Meters are still required to calibrate CGMs and for guidance in making therapy and meal decisions. CGM is important because, in addition to providing the glucose level, it provides the direction and rate of glucose change with the push of a button and alerts users when glucose is too low or too high.
Diabetes affects 29.1 million Americans and is the 7th leading cause of death in the United States.2 With diabetes, the body cannot produce or use the hormone insulin effectively, causing a buildup of glucose, or sugar, in the blood. Obesity, physical inactivity and poor diet are risk factors for the development of diabetes.3 People with diabetes who take insulin must monitor their blood glucose levels frequently. Uncontrolled glucose can cause health complications and even death.4,5
About Dexcom, Inc. Dexcom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. With exceptional performance, patient comfort and lifestyle flexibility at the heart of its technology, users have consistently ranked Dexcom highest in customer satisfaction and loyalty. For more information on the Dexcom CGM, visit www.dexcom.com.
Caren Begun, 201-396-8551
To view multimedia assets, please visit: http://www.dexcom.com/media.
Steven Pacelli, 858-200-0200
References 1. Clarke SF and Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;(3)2:83-93. 2. 2014 National Diabetes Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf Accessed March 31, 2015. 3. Data and Statistics, World Health Organization Web site, Available at: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/diabetes/data-and-statistics 4. Hyperglycemia (High blood glucose). American Diabetes Association Web site. http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hyperglycemia.html. Updated August 5, 2013. Accessed December 3, 2013. 5. Hypoglycemia (Low blood glucose). American Diabetes Association Web site. http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hypoglycemia-low-blood.html. Updated July 16, 2013. Accessed December 3, 2013.
SOURCE Dexcom, Inc.